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Abstract: The pain of childbirth is arguably the most severe pain most women will endure 
in their lifetimes. The pain of the early first stage of labor arises from dilation of the lower 
uterine segment and cervix. Pain from the late first stage and second stage of labor arises from 
descent of the fetus in the birth canal, resulting in distension and tearing of tissues in the vagina 
and perineum. An array of regional nerve blocks, systemic analgesic, and nonpharmacologic 
techniques are currently used for labor analgesia. Nonpharmacologic methods are commonly 
used, but the effectiveness of these techniques generally lacks rigorous scientific study. 
Continuous labor support has been shown to decrease the use of pharmacologic analgesia 
and shorten labor. Intradermal water injections decrease back labor pain. Neuraxial labor 
analgesia (most commonly epidural or combined spinal-epidural) is the most effective method 
of pain relief during childbirth, and the only method that provides complete analgesia with-
out maternal or fetal sedation. Current techniques commonly combine a low dose of local 
anesthetic (bupivacaine or ropivacaine) with a lipid soluble opioid (fentanyl or sufentanil). 
Neuraxial analgesia does not increase the rate of cesarean delivery compared to systemic 
opioid analgesia; however, dense neuraxial analgesia may increase the risk of instrumental 
vaginal delivery.
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The pain of childbirth is arguably the most severe pain most women will endure 
in their lifetimes. The modern era of childbirth analgesia began in 1847 when 
Dr James Young Simpson administered ether to a woman in childbirth, and later in 
the same year, chloroform. Several years later John Snow successfully administered 
chloroform to Queen Victoria during the birth of her eighth child. Dämmerschlaf, 
or “twilight sleep,” a combination of systemic morphine and scopolamine, was first 
described in the early twentieth century.1 Regional anesthesia was introduced in 1884 
when Carl Koller described the use of cocaine to anesthetize the eye. Descriptions 
of spinal, lumbar and caudal epidural, paravertebral, and pudendal nerve blocks for 
obstetrics were published between 1900 and 1930.2 Continuous neuraxial analgesia, 
as it is practiced today, had its birth in the mid-twentieth century when Hingson 
and Edwards published the first report of continuous caudal analgesia for childbirth 
in 1943.3
An array of regional nerve blocks, systemic analgesic, and nonpharmacologic 
techniques are currently used for labor analgesia. This review will summarize the International Journal of Women’s Health 2009:1 140
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physiology of childbirth pain, labor analgesic techniques, and 
the effects of labor analgesia on the mother and infant.
Pathophysiology of childbirth pain
Although the amount of pain and suffering associated with 
labor and vaginal delivery varies widely among parturients, 
few well-designed studies on the prevalence, intensity, 
and quality of labor pain have been performed. Melzack 
and colleagues used the McGill Pain Questionnaire to 
measure pain during labor and delivery (Figure 1).4 
Nulliparous women had a higher total mean pain rating 
index (PRI) than parous women. Significant differences 
were also found between nulliparous and parous women 
in the sensory qualities of pain. Although scores ranged 
from mild to excruciating, the PRI scores of laboring 
women were 8 to 10 points higher than those associated 
with cancer pain, phantom limb pain, and postherpetic 
neuralgia.
Pain during the first stage of labor (start of labor until 
complete cervical dilation) originates predominantly in the 
cervix and the lower uterine segment, rather than the body of 
the uterus.5,6 Dilation of the cervix and lower uterine segment 
results in tissue distension, stretching, and tearing. During the 
late first stage and second stage of labor (complete cervical 
dilation until delivery) the fetus descends in the birth canal 
and the progressively greater pressure of the fetus on the 
vagina and perineum become additional sources of pain. 
Distension of the birth canal causes intense stretching and 
Chronic pain syndromes
and
labor pain
McGill questionnaire
pain scores
(PRI)
Pain after
accidents
Causalgia
Digit
amputation Nulliparas
Nulliparas
Multiparas
(no prepared childbirth training)
(prepared childbirth training)
(trained and untrained)
Chronic back pain
Cancer pain
(nonterminal)
Phantom limb pain
Postherpetic neuralgia
Toothache
Arthritis
Bruise
Laceration
Sprain
Fracture
Cut
50
40
30
20
10
Figure 1 Comparison of pain scores using the McGill Pain Questionnaire obtained from women during labor and from patients in general hospital clinics and an emergency 
department.   The pain rating index (PrI) represents the sum of the rank values for all words chosen from 20 sets of pain descriptions. From Melzack r. The myth of painless 
childbirth [The John J. Bonica Lecture]. Pain. 1984;19(4):321–337.4 Copyright © 1984. This figure has been reproduced with permission of the International Association for the 
study of Pain® (IASP®). The figure may not be reproduced for any other purpose without permission.International Journal of Women’s Health 2009:1 141
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tearing of fascia and subcutaneous tissues and pressure on 
the skeletal muscles of the perineum.
Painful impulses from the lower uterine segment and 
cervix are transmitted via visceral afferent nerve fibers which 
accompany sympathetic nerve fibers and enter the spinal cord 
at the tenth, eleventh, and twelfth thoracic and first lumbar 
spinal segments (Figure 2). Somatic sensory impulses from the 
vagina and perineum are transmitted via the pudendal nerves 
to the second, third and fourth sacral spinal segments.
As is typical of visceral pain, the pain of the first stage 
of labor is often referred to the dermatomes supplied by the 
same spinal cord segments that receive input from the uterus 
and cervix (T10 to L1). Additionally, during the late first 
stage and second stage of labor, stimulation of pain-sensitive 
structures within the pelvic cavity, and pressure on one or 
more roots of the lumbosacral plexus may result in aching, 
burning, or cramping discomfort in the thigh, legs, and 
lower back. Stimulation of these structures contributes 
to pain referred to the lower lumbar and sacral segments. 
The pain may be severe if the fetus is in an abnormal position 
(eg, occiput posterior).
Visceral C-fibers transmitting pain from the uterus and 
cervix terminate in the spinal cord in the ipsilateral superficial 
and deep dorsal horn and the ventral horn in a loose network 
of synapses, as well as crossing the midline to the contralat-
eral dorsal horn with extensive rostrocaudal extension.6 In 
contrast, somatic afferent fibers terminate in the ipsilateral 
superficial laminae of the dorsal horn with minimal rostro-
caudal fiber extension. Thus, first stage labor pain tends to be 
diffuse in nature compared to second stage labor pain.
Knowledge of the anatomic basis of the transmission of 
labor pain underlies the current treatment of labor pain using 
regional anesthesia techniques. The visceral pain of the first 
stage of labor can be blocked with bilateral paracervical 
plexus or lumbar sympathetic blockade (Figure 2). Sacral 
somatic pain caused by descent of the fetus in the birth canal 
can be blocked with bilateral pudendal nerve blockade. 
Epidural and intrathecal blockade (neuraxial blockade) 
Paravertebral blocks T10-L1
Sacral nerve-root blocks S2-S4
Pudendal block
Paracervical block
Low caudal or true saddle block
Lumbar sympathetic block
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Figure 2 Transmission of labor pain. Labor pain has a visceral component and a somatic component. Noxious impulses from the uterus and cervix follow afferent sensory-nerve 
fibers that accompany sympathetic nerves, traveling through the paracervical region and the pelvic and hypogastric plexus to enter the lumbar sympathetic chain and the 
dorsal horn of the spinal cord through the white rami communicantes of the T10, T11, T12, and L1 spinal nerves. Noxious impulses from the vagina and perineum travel via 
the pudendal nerve to enter the spinal cord at S2 to S4. reprinted with permission from eltzschig HK, Lieberman eS, Camann Wr. regional anesthesia and analgesia for labor 
and delivery. N Eng J Med. 2003;348(4):319–332.136 Copyright © 2003 Massachusetts Medical Society.   All rights reserved.International Journal of Women’s Health 2009:1 142
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provides complete analgesia for both the first and second 
stages of labor.
A number of physical and psychologic factors may influ-
ence the severity and duration of labor pain and suffering. 
Physical factors include maternal age, parity,7 and maternal 
condition, the condition of the cervix at the onset of labor, 
and the relationship of the size and position of the fetus 
to the size of the birth canal. Many of these factors are 
interrelated. Generally, older nulliparas experience longer 
and more painful labors than younger nulliparas.4 The parous 
cervix begins to soften even before the onset of labor and 
is less sensitive than the nulliparous cervix. The intensity 
of uterine contractions in early labor tends to be greater in 
nulliparous than parous women, whereas the reverse is true 
as labor advances. Dystocia caused by a contracted pelvis, 
a large baby, or abnormal presentation or position is usually 
associated with greater pain. Women who go on to have 
a cesarean delivery after labor have more breakthrough 
pain during epidural analgesia8 and require higher opioid 
doses during systemic analgesia9 than women who deliver 
vaginally. A history of dysmenorrhea, maternal fatigue, and 
general debility are associated with higher levels of pain.4
Psychological factors, including fear, apprehension, and 
anxiety,10 and the presence of family members11 or birth-
ing companions12 also influence pain and suffering during 
childbirth. Education, intense motivation, and cultural fac-
tors influence the affective and behavioral dimensions of 
pain, although they probably minimally affect actual pain 
sensation. For example, Bonica13 observed that women who 
had predelivery training in psychoprophylaxis manifested 
little or no pain behavior during childbirth, although when 
questioned the next day, most of them indicated the process 
had been quite painful.
effects of labor pain on the mother  
and fetus
Labor pain per se, as well as the tissue damage produced by 
childbirth, is associated with direct and indirect effects on the 
mother and fetus. Responses to pain, which include marked 
stimulation of respiration and circulation, as well as hypotha-
lamic autonomic centers of neuroendocrine function, limbic 
structures; and psychodynamic behaviors such as anxiety 
and apprehension, may produce deleterious consequences 
to the mother and fetus/newborn. Many of these responses 
are mitigated by effective pain relief.
Labor pain is a powerful respiratory stimulus, resulting 
in a marked increase in minute ventilation and oxygen con-
sumption during contractions. Compensatory hypoventilation 
between contractions may cause transient maternal 
hypoxemia, and potentially, fetal hypoxemia. These periods 
of hypoventilation may be exacerbated by analgesic tech-
niques that result in respiratory depression (eg, systemic 
opioid analgesia). Hyperventilation causes severe respira-
tory alkalosis and a left shift of the maternal oxyhemoglobin 
dissociation curve, thus diminishing oxygen transfer to 
the fetus.
The pain and stress of labor activate the sympa-
thetic nervous system, resulting in an increase in plasma 
catecholamine concentrations, cardiac output and blood 
pressure. Circulating epinephrine and norepinephrine levels 
increase by 200% to 600% during unmedicated labor14 and 
this increase in catecholamines is associated with a decrease 
in uterine blood flow.15 Severe pain, anxiety and increased 
catecholamine levels are associated with prolonged or dys-
functional labor.16 Epinephrine is a tocolytic and physicians 
have long observed that an apparent dysfunctional labor 
pattern can be corrected with effective analgesia.17 Finally, 
unrelieved severe pain may result in serious mental health 
disturbances that interfere with maternal–neonatal bonding, 
future sexual relationships, and contribute to postpartum 
depression,4 and rarely, to posttraumatic stress disorder.18
Independent of pain, labor and delivery are associated 
with marked stimulation of the cardiorespiratory system. 
Uterine contractions displace blood from the uterus to the 
central circulation (autotransfusion), thus increase cardiac 
work. Contractions also decrease uteroplacental perfusion, 
since the uterus is only perfused during uterine diastole. 
The healthy parturient readily tolerates the large increase in 
cardiac work, but parturients with heart disease, pulmonary 
hypertension, or severe pre-eclampsia may not tolerate these 
changes without adverse outcome. Similarly, while the 
healthy fetus easily tolerates the changes in uterine blood flow 
and oxygen delivery, these changes may be deleterious in 
the setting of uteroplacental insufficiency (eg, pre-eclampsia, 
intrauterine growth retardation, diabetes mellitus). For these 
high risk mothers and fetuses, effective analgesia may 
contribute to better outcomes.
Responses to noxious stimuli during childbirth are the net 
effects of complex interactions of multiple neurohormonal 
systems, modulating influences, and psychological 
factors. These interactions are responsible for the complex 
physiologic, behavioral, and affective responses that 
characterize childbirth pain and response to analgesia. Our 
current understanding of the neurophysiologic basis of 
childbirth pain is fairly superficial. Better understanding of 
the pain pathways, neurotransmitters and receptors involved International Journal of Women’s Health 2009:1 143
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in this complex pain will likely present new opportunities 
for the effective treatment of childbirth pain.
Nonpharmacologic methods  
of labor analgesia
Childbirth education, emotional support, massage, aroma 
therapy, audio-therapy, and therapeutic use of hot and cold 
have been promulgated as nonpharmacologic methods to 
relieve or mitigate the pain and suffering of childbirth. 
Techniques that require specialized training or equipment 
include hydrotherapy, intradermal water injections, 
biofeedback, transcutaneous electrical nerve stimulation 
(TENS), acupuncture or acupressure, and hypnosis. Most of 
these techniques have not been subject to rigorous scientific 
study; therefore, conclusions about their efficacy are not 
possible.19–21
Antenatal childbirth education is widely practiced. 
Studies of the role of childbirth education in influencing 
outcomes such as use of analgesia, duration of labor, mode 
of delivery, and incidence of nonreassuring fetal status, are 
of poor scientific quality and results are inconsistent. For 
example, observational studies have found that participa-
tion in childbirth education classes is associated with a 
decreased rate of neuraxial analgesia,22,23 no change,24 or 
an increased rate.25
The parturient’s partner or a friend(s) often provide 
emotional support during childbirth. There is no consistent 
evidence that this type of support effects childbirth pain. 
“Continuous labor support” refers to the nonmedical support 
of the parturient by a trained person, eg, a doula.19 Controlled 
trials and several systematic analyses have concluded 
that women who received continuous labor support have 
shorter labors, fewer operative deliveries, fewer analgesic 
interventions, and greater satisfaction.26–28 Neonatal outcome 
is not altered.
In general, the results from North American trials of 
continuous labor support do not appear as striking as those 
from Europe or Africa.19 Subgroup analysis of the most 
recent meta-analysis suggests that benefits are greater when 
the support person is not a member of the hospital staff.27 
In any case, all women deserve emotional support during 
childbirth, whether it is provided by the partner, a family 
member, a nonprofessional labor companion, or professional 
hospital staff.
TENS is the application of low-intensity, high-frequency 
electrical impulses via surface electrodes applied to the 
lower back. The buzzing, electrical current sensation caused 
by the TENS unit may reduce the mother’s awareness of 
contraction pain. The parturient controls the degree of stimulation. 
TENS is widely used in the United Kingdom and Scandinavia 
for childbirth analgesia. Studies of TENS are inconsistent, but 
in general, labor pain does not appear to be lessened, nor is the 
use of other analgesic modalities.19,29
Hydrotherapy is the immersion of the parturient in warm 
water (deep enough to cover the abdomen) during labor (not 
birth). Systematic reviews of randomized controlled trials 
have concluded that women who use hydrotherapy experi-
ence less pain and use less analgesia, without change in the 
duration of labor, rate of operative delivery, or neonatal 
outcome.26,30
Intradermal water injection consists of the injection of 
0.05 to 0.1 mL of sterile water, using an insulin or tuberculin 
syringe, at four sites on the lower back (Figure 3). The 
injections are acutely painful for 20 to 30 seconds, but as the 
injection pain fades, so does lower back pain.19 Randomized 
controlled trials have found that the technique is effective 
in reducing severe back pain during labor, although the rate 
of use of other analgesic modalities was not different in the 
treatment compared to control group.19,31 There are no known 
side effects to the mother and fetus.
Prenatal training of the mother, and sometimes her 
partner, by a trained hypnotherapist is required to learn 
the technique of self-hypnosis. A meta-analysis of five 
randomized controlled trials (n = 749) concluded that the 
use of pharmacologic analgesia methods was decreased in 
the hypnosis compared to controlled group.32 Data were 
inconclusive or limited regarding progress of labor and 
Posterior superior iliac
spines (“Dimples of
Venus”)
Figure 3 Placement of intradermal water blocks: 4 intradermal injections of 0.05 to 
0.1 mL of sterile water to form 4 small blebs over each posterior superior iliac spine 
and 3 cm below and 1 cm medial to each spine.   The exact locations of the injections do 
not appear to be critical to the block success. reprinted with permission from Simkin P, 
Bolding A. Update on nonpharmacologic approaches to relieve labor pain and prevent 
suffering. J Midwifery Womens Health. 2004;49(6):489–504.19 Copyright © 2004 elsevier.International Journal of Women’s Health 2009:1 144
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neonatal outcomes. Hypnosis by a trained individual during 
childbirth is labor-intensive and has not been studied in 
controlled trials.
Acupuncture is a component of traditional Chinese medi-
cine that has gained popularity in some Western cultures in 
recent years. In randomized controlled trials conducted in 
Scandinavian countries33–36 and Iran,37 women randomized 
to acupuncture had modestly lower pain scores, and lower 
use of epidural and systemic opioid analgesia than women 
randomized to control groups (no or “false” acupuncture). 
Whether these results can be replicated in other Western 
societies requires further study.
Systemic analgesia
Current methods of systemic labor analgesia are inhalation 
analgesia and systemic opioid analgesia. Inhalation analgesia 
for labor and vaginal delivery is unusual in the United States, 
but is more common in other countries. Nitrous oxide is the 
inhaled anesthetic agent currently in common use. It is avail-
able in the United Kingdom as Entonox®, a mixture of 50% 
nitrous oxide and 50% oxygen. Special scavenging equip-
ment is necessary to ensure the safe administration of the drug 
without contamination of environment. The mother should 
be taught to inhale the mixture correctly, so that peak brain 
nitrous oxide concentration coincides with peak contraction 
pain. Use of nitrous oxide for labor analgesia is controversial, 
as studies are conflicting as to whether the drug actually 
provides benefit.38–40 The intermittent use of nitrous oxide, 
however, appears safe for the mother and fetus/neonate. The 
risk of maternal hypoxemia may be increased by concomitant 
use of nitrous oxide and systemic opioids.41,42
In the past, volatile halogenated anesthetic agents have 
been used for labor analgesia. Similar to inhaled nitrous 
oxide analgesia, analgesia is incomplete, as doses that provide 
significant analgesia are also associated with significant 
maternal sedation. Special equipment, including scavenging 
equipment, is necessary for the safe administration of volatile 
anesthetic agents in the labor and delivery room environment. 
The lower blood-gas solubility coefficient of the newer agents, 
desflurane and sevoflurane, theoretically confer an advantage 
over the older agents (eg, methoxyflurane, halothane) because 
of the more rapid onset and offset of analgesia. In a small 
study, pain relief scores were significantly higher in women 
who received sevoflurane 0.8% compared to nitrous oxide 
50%, and women preferred sevoflurane.43 However, sevoflu-
rane was associated with higher sedation scores, and whether 
or not volatile agents interfere with the progress of labor (they 
inhibit uterine contractility) remains to be determined.
Systemic opioid analgesia is widely used around the 
world, although its use for labor analgesia lacks rigorous 
scientific study. There is a high incidence of maternal side 
effects, and at best, analgesia is incomplete. Existing data 
suggest that opioids provide little significant analgesia.44–46 
Although meperidine is the most commonly used systemic 
opioid, there are few studies comparing opioids and little 
scientific evidence that one opioid is better than another. 
All have similar, dose-related, maternal and fetal side 
effects. Maternal side effects include nausea, vomiting, 
dysphoria, delayed gastric emptying and respiratory 
depression. All opioids cross the placenta. In utero opioid 
exposure results in a slower fetal heart rate and decreased 
beat-to-beat variability.47 The risk of neonatal respiratory 
depression depends on the dose and timing of maternal 
opioid administration. The active metabolite of meperidine, 
normeperidine, has a half-life of 60 hours in neonates.48
Theoretically, patient-controlled intravenous opioid 
analgesia (PCIA) has advantages compared to nurse- or 
midwife-administered opioid analgesia. These advantages 
include superior analgesia with smaller drug doses, result-
ing in a lower incidence of side effects, and patient control 
of analgesia. Studies of PCIA meperidine,49 nalbuphine,50 
fentanyl,51 and more recently, remifentanil, have been 
reported.52–54
Remifentanil has theoretical advantages for PCIA com-
pared to other opioids because of its short latency (time to 
peak effect after IV administration is 60 to 90 seconds55). 
Additionally, because of its rapid metabolism by plasma 
esterases, it may be safer for the neonate. Remifentanil PCIA, 
with and without background infusions, has been described. 
Bolus doses have ranged from 0.2 µg/kg to 1 µg/kg with 
lock-out intervals from 1 to 5 minutes,52–54,56 and infusion 
rates from 0.025 µg/kg/min to 0.1 µg/kg/min.52,56 Similar to 
other systemic opioid techniques, data are inconsistent as to 
whether remifentanil PCIA can provide satisfactory analgesia 
without an unacceptably high incidence of side effects.56,57
Neuraxial analgesia
Neuraxial labor analgesia is the most complete and effective 
method of pain relief during childbirth, and the only method 
that provides complete analgesia without maternal or fetal 
sedation. Over the past 40 years in the United States, the use 
of neuraxial analgesia for childbirth has increased dramati-
cally.58 In the most recent US survey performed in 2001, over 
60% of women in large maternity hospitals received neuraxial 
analgesia during labor.58 At the Prentice Women’s Hospital 
in Chicago (author’s institution) 90% of laboring women International Journal of Women’s Health 2009:1 145
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receive neuraxial analgesia during labor. The United Kingdom 
National Health Service Maternity Statistics of 2005–2006 
reported that one third of parturients chose neuraxial anal-
gesia during childbirth.59 Advantages and disadvantages 
of neuraxial labor analgesia are listed in Table 1. The most 
common techniques are continuous lumbar epidural analgesia, 
and combined spinal–epidural analgesia. Because the dura-
tion of most labors are longer than the duration of action of 
most neuraxial analgesics, single-shot spinal and epidural 
techniques lack flexibility. Caudal analgesia is uncommon in 
modern-day labor analgesia because injection of large doses 
of local anesthetics is required to obtain surgical anesthesia 
for cesarean delivery. Continuous spinal analgesia requires 
dural puncture with a large-bore needle and intrathecal place-
ment of an “epidural” catheter, as microcatheters, at least in 
the United States, are not commercially available. The large 
dural puncture results in an unacceptably high incidence of 
postdural puncture (spinal) headache. However, the benefits 
of continuous spinal anesthesia may outweigh the risks in a 
subset of high-risk patients.
Contraindications to neuraxial analgesia and anesthesia 
include patient refusal, pre-existing coagulopathy, infection 
at the puncture site, and lack of experienced anesthesia 
providers. Relative contraindications include hemorrhage 
or other causes of hypovolemia, untreated systemic 
infection, preload-dependent disease states, and lumbar 
spine pathology.
Lumbar epidural analgesia has been the mainstay of 
neuraxial labor analgesia for many years. Placement of 
an epidural catheter allows maintenance of analgesia until 
after delivery. Neuraxial anesthesia for emergency cesarean 
delivery is associated with decreased maternal morbidity and 
mortality compared to general anesthesia,60 therefore, the 
ability to quickly convert from epidural analgesia to epidural 
anesthesia is a major benefit of epidural analgesia.
Randomized studies consistently demonstrate that 
pain scores are lower and patients are more satisfied with 
epidural analgesia compared to other forms of nonneuraxial 
analgesia.61,62 Injection of anesthetics in the lumbar epidural 
space allows spread of the anesthetic solution both cephalad 
and caudad. Neural blockade to the T10 to L1 spinal seg-
ments is necessary to relieve the pain of uterine contraction 
and cervical dilation, whereas blockade of the sacral derma-
tomes S2 to S4 is necessary to block the pain of vaginal and 
perineal distention.
Lumbar epidural analgesia is usually initiated in the sit-
ting or lateral position. The epidural space is identified with 
a 17- or 18-gauge epidural needle and a 19- or 20-gauge 
flexible catheter is passed through the needle into the epi-
dural space; the epidural needle is removed and the catheter 
is secured. A test dose of lidocaine or bupivacaine with 
epinephrine is frequently administered to rule out intrathecal 
or intravascular catheter placement. Unintentional intravas-
cular injection of local anesthetics can result in systemic 
toxicity and unintentional intrathecal injection can result in 
total spinal anesthesia, both with disastrous consequences to 
the mother and baby. Pregnant women are very difficult to 
resuscitate in general, particularly after cardiac arrest from 
local anesthetic cardiac toxicity.63
After ascertaining that the epidural catheter is not malpo-
sitioned, epidural analgesia is initiated by bolus injection of 
anesthetic(s) into the epidural space. Analgesia is maintained 
with intermittent bolus injections or a continuous infusion. 
The catheter is removed after delivery when there is no 
further need for analgesia/anesthesia.
Combined spinal-epidural (CSE) analgesia has become 
increasingly popular in the past decade. Onset of analgesia 
is significantly faster with CSE compared to epidural anal-
gesia (2 to 5 minutes vs 15 to 20 minutes).64 In early labor, 
the intrathecal injection of lipid soluble opioids without 
local anesthetics results in complete analgesia while avoid-
ing motor blockade and decreasing the incidence of hypo-
tension. This technique is ideal for parturients who wish to 
ambulate. The effective opioid dose is significantly less than 
Table 1 Advantages and disadvantages of neuraxial labor analgesia
Advantages Disadvantages
•  Complete analgesia
•  No maternal sedation
•  Mother able to enjoy and participate in birth
•  Mitigates deleterious reflex responses to pain
•  Minimal or no neonatal sedation
•    Continuous analgesia can be converted to surgical anesthesia 
for urgent or emergency cesarean delivery: avoids need for general 
anesthesia and risk of airway catastrophe
•  requires a skilled anesthesia provider
•  Occasional failed block
•    Sympathectomy leading to maternal hypotension and decreased 
uteroplacental perfusion
•    Prolonged 2nd stage of labor and possible increased risk of instrumental 
vaginal delivery
•    Contraindicated in parturient with coagulopathy or receiving 
anticoagulantsInternational Journal of Women’s Health 2009:1 146
Wong Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
that required for systemic or epidural administration and 
does not result in sedation. The addition of local anesthetic 
to a lipid soluble opioid results in sacral analgesia within 
several minutes; whereas it may take several hours after the 
lumber epidural injection of dilute local anesthetic solu-
tions to obtain complete sacral analgesia. Therefore, CSE 
analgesia provides more complete analgesia for women 
in advanced stages of labor, or women whose labor is 
progressing rapidly and for whom sacral analgesia is an 
important component of successful neuraxial analgesia. 
Finally, use of the CSE technique may decrease the inci-
dence of failed epidural analgesia (eg, a nonfunctioning 
epidural catheter).65
There are several disadvantages of CSE analgesia. Dural 
puncture is required, albeit with a small-gauge needle. The 
risk of postdural (spinal) headache does not seem to be 
increased with CSE compared to epidural analgesia.66 The 
incidence of pruritus is higher with intrathecal versus epi-
dural opioids.67 After the initiation of CSE analgesia it will 
be unclear for 1 to 2 hours whether the epidural catheter is 
functional (eg, properly sited in the epidural space). There-
fore, CSE analgesia may not be the technique of choice if 
a functioning epidural catheter is critical to the safe care of 
the patient (eg, in the presence of a nonreassuring fetal heart 
rate pattern, or an anticipated difficult airway).
The most common CSE technique for labor analgesia is 
the needle-through-needle technique initiated in a mid- or 
low-lumbar interspinous space. The epidural space is iden-
tified with an epidural needle in the standard fashion; the 
needle then functions as an introducer for a long, small-gauge 
(25- to 27-gauge) pencil-point spinal needle. After the tip of 
the spinal needle punctures the dura (Figure 4), the intrathecal 
drug(s) is injected, the spinal needle is withdrawn, and an 
epidural catheter is threaded through the epidural needle into 
the epidural space. Analgesia is maintained via the epidural 
catheter, as with traditional epidural analgesia.
Drugs for neuraxial labor analgesia
The ideal analgesic drug for neuraxial labor analgesia would 
provide rapid onset of effective analgesia with minimal motor 
blockade, minimal risk of maternal toxicity, and negligible 
effect on uterine activity and uteroplacental perfusion. 
Placental transfer would be limited, as would direct or indi-
rect effects on the fetus and neonate. Finally, the ideal drug 
would have a long duration of action. Unfortunately, this 
perfect drug does not currently exist, but the combination 
of a long-acting amide local anesthetic with a lipid soluble 
opioid allows this goal to be approached.
Traditionally, local anesthetics, in particular bupivacaine, 
were administered to block both the visceral and somatic pain 
of labor. The discovery three decades ago of opiate receptors 
in the dorsal horn of the spinal cord68 opened up a new era in 
neuraxial labor analgesia. Neuraxial opioid administration 
results in opioid binding to these spinal cord receptors with 
minimal systemic opioid side effects. Intrathecal opioids 
alone effectively relieve the visceral pain of the early first 
stage of labor, although they need to be combined with a 
local anesthetic to effectively block the somatic pain of the 
late first stage and the second stage of labor.
Neuraxial local anesthetics and opioids appear to act 
synergistically to provide neuraxial analgesia.69–71 The 
combination of a local anesthetic with a lipid-soluble opioid 
allows the use of lower doses of each agent, thus minimizing 
undesirable side effects. The local anesthetic dose required 
for effective epidural analgesia, when used alone without an 
opioid, is associated with an unacceptably high incidence of 
motor blockade. Similarly, high doses of epidural opioid, 
when used alone, are required for satisfactory analgesia, and 
these doses are associated with significant systemic absorp-
tion and systemic side effects. Latency is an important aspect 
of labor analgesia; the addition of a lipid soluble opioid to the 
long-acting/long-latency local anesthetics shortens latency.72 
Thus, contemporary neuraxial labor analgesia most often 
incorporates low doses of a long-acting local anesthetic with 
a lipid-soluble opioid.
Figure 4 Cross-sectional view of the combined spinal-epidural (CSe) needle-through-
needle technique. The large-gauge epidural needle is sited in the epidural space and 
the small-gauge spinal needle is passed through the epidural needle and punctures 
the dura to site in the subarachnoid space. reprinted with permission from Birnbach 
DJ, Ojea LS. Combined spinal-epidural (CSe) for labor and delivery. Int Anesthesiol Clin. 
2002;40(4):27–48.137 Copyright © 2002 Lippincott Williams & Wilkins.International Journal of Women’s Health 2009:1 147
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Bupivacaine has been the mainstay of epidural analgesia 
for many years (Table 2). It is most often used in combina-
tion with fentanyl or sufentanil to induce epidural and CSE 
analgesia. Placental transfer is minimal because the drug is 
highly protein bound; duration of analgesia is approximately 
2 hours. Although lidocaine and 2-chloroprocaine have 
shorter latencies than bupivacaine, their duration of analgesia 
is also significantly shorter, thus limiting their usefulness for 
routine labor analgesia. Additionally, lidocaine is less protein 
bound than bupivacaine, and therefore has a higher umbilical 
vein/maternal vein ratio.73
Ropivacaine is a homologue of bupivacaine, formulated 
as a single levorotary enantiomer. Its latency and duration of 
action are similar to bupivacaine,74 but it has less potential for 
cardiac toxicity. Although potency studies suggest that ropi-
vacaine is approximately 40% less potent than bupivacaine,75 
the results of clinical studies comparing low concentrations 
of ropivacaine and bupivacaine for labor analgesia suggest 
the two drugs are equipotent in terms of sensory blockade for 
labor analgesia.76,77 Compared to an equipotent sensory dose 
of bupivacaine, ropivacaine may be associated with less motor 
blockade;76,78 however, this characteristic may not be clinically 
relevant when low doses of bupivacaine are used.
Levobupivacaine is the S-enantiomer of bupivacaine 
(which is a racemic mixture), and as such, is also less car-
diotoxic than bupivacaine. Onset and duration of action 
are similar to those of ropivacaine and bupivacaine, but 
levobupivacaine is associated with less motor blockade than 
bupivacaine.76,78 Levobupivacaine is not available in the 
United States. Neither ropivacaine nor levobupivacaine are 
approved for spinal use in the United States although their 
intrathecal use for labor analgesia has been reported from 
institutions outside the United States.79
Fentanyl or sufentanil is commonly combined with a 
local anesthetic for spinal and epidural analgesia. Both 
drugs have a rapid onset (5 to 10 minutes).72,80 Their short 
duration of action (60 to 90 minutes) is overcome by main-
taining analgesia with a continuous epidural infusion. Doses 
commonly used for initiation and maintenance of neuraxial 
analgesia have been shown to be safe for both the mother 
and neonate.81,82 In contrast, neuraxial morphine has a much 
slower onset (30 to 60 minutes) and longer duration of action 
(12 to 24 hours).83 In most settings the long duration of action 
is not beneficial, and the bothersome side effects of morphine 
(pruritus, nausea and vomiting) continue to be present after 
delivery. Low-dose morphine (0.25 mg), however, has 
been successfully combined with intrathecal bupivacaine 
and fentanyl for labor analgesia; this combination resulted 
in short latency and a prolonged duration of analgesia.84–86 
This combination of drugs may be particularly useful in 
settings where continuous epidural infusion techniques are 
impractical and single-shot spinal techniques are used for 
labor analgesia.84
Adjuvants for neuraxial labor analgesia include epineph-
rine and clonidine. Epinephrine may contribute to analgesia 
by binding to spinal cord α2-adrenergic receptors87 and 
decreasing the uptake of local anesthetics and opioids from 
the epidural space secondary to vasoconstriction.88 Clonidine 
also binds to α2-adrenergic receptors and has been shown 
to supplement epidural labor analgesia. Clonidine is not 
approved for use in obstetric patients in the United States, 
however, because of the risks of sedation and hypotension.
Maintenance of neuraxial labor analgesia
CSE and epidural analgesia may be maintained with intermit-
tent bolus injection, continuous epidural infusion, or patient 
controlled epidural analgesia, with or without a background 
infusion. A dilute solution of bupivacaine or ropivacaine 
combined with fentanyl or sufentanil is commonly used 
(Table 3). Continuous epidural infusions result in less need 
for bolus injections89 and increased patient satisfaction,90 but 
higher total drug dose89,90 compared to intermittent injections. 
However, the infusion of lower concentration-bupivacaine at 
a higher rate may result in similar analgesia with less motor 
block and no increase in total dose.90
Patient-controlled epidural analgesia (PCEA) allows for 
both a continuous epidural infusion and patient-titrated bolus 
injections. PCEA resulted in greater patient satisfaction91,92 
and a lower average hourly dose of bupivacaine (and 
therefore less motor block),92–94 The protocols for PCEA 
vary widely. At one extreme, most of the hourly dose is 
Table 2 Drugs for initiation of neuraxial labor analgesia
Initiation 
of analgesia
Epidural 
analgesiaa
Spinal 
analgesia
Local anestheticsb
  Bupivacaine 0.0625%–0.125% 1.25–2.5 mg
  ropivacaine 0.08%–0.2% 2.5–4.5 mg
  Levobupivacaine 0.0625%–0.125% 2.5–4.5 mg
Opioidsb
  Fentanyl 50–100 µg 15–25 µg
  Sufentanil 5–10 µg 1.5–5 µg
aThe volume required to initiate epidural labor analgesia is 5 to 15 mL of local 
anesthetic solution.
bThe local anesthetic dose/concentration and the fentanyl or sufentanil dose are 
reduced if the drugs are combined, or if a local anesthetic-containing epidural test 
dose is administered before the initiation dose.International Journal of Women’s Health 2009:1 148
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administered via a background infusion which the parturient 
may supplement with self-administered boluses. At the other 
extreme, there is no background infusion and the entire dose 
is self-administered via intermittent boluses. Bupivacaine 
consumption is higher with background infusions compared 
to a pure PCEA technique without a background infusion.95 
In a recent review, Halpern and Carvalho suggested that 
administration of approximately one third of the hourly 
dose via a continuous infusion may minimize the incidence 
of breakthrough pain while optimizing individual patient 
titration and drug dose.96 Common PCEA parameters include 
a background infusion of 5 to 8 mL/hour, a bolus dose of 5 
to 10 mL, and a lock-out interval of 10 to 20 minutes.
The term “walking” or “mobile” epidural analgesia 
was first coined to describe CSE opioid analgesia because 
motor function was maintained and the ability to walk was 
not impaired.97 However, the term can be applied to any 
neuraxial analgesic technique that allows safe ambulation. 
Although the concept of the “walking epidural” is popular 
in the lay press, many women, once comfortable, prefer to 
rest or sleep rather than ambulate. However, the ability to 
walk to the toilet, or sit in a chair at the bedside, is desir-
able to many laboring women. Although ambulation per se 
has not been shown to positively or negatively affect the 
progress or outcome of labor, dense motor blockade may 
adversely affect the spontaneous vaginal delivery rate (vide 
infra). Thus, the goal of the anesthesia provider should be 
to minimize motor blockade, whether or not the patient 
wishes to ambulate.
Several safeguards are necessary for safe ambulation. 
After initiation of analgesia, parturients are usually 
monitored in bed for maternal hypotension and fetal heart 
rate changes for 30 to 45 minutes. Orthostatic blood pressure 
and heart rate should be measured, and motor function and 
balance must be assessed. The patient should not ambulate 
alone as altered dorsal column function (eg, proprioception) 
may interfere with balance in some patients despite lack 
of motor blockade.98
Side effects of neuraxial labor analgesia
Hypotension and pruritus are common side effects of neuraxial 
analgesia; less common side effects include fetal bradycardia 
and maternal hyperthermia. Hypotension is the result of local 
anesthetic blockade of the sympathetic nervous system, lead-
ing to vasodilation, increased venous capacitance, decreased 
preload, and decreased cardiac output. Because uterine blood 
flow is not autoregulated, a decrease in maternal blood pressure 
results in a decrease in uteroplacental perfusion. Therefore, 
maternal blood pressure and fetal heart rate should be moni-
tored for 15 to 30 minutes after the induction of neuroblockade. 
The mother should be positioned to avoid aortocaval compres-
sion and hypotension should be treated with small bolus doses 
of intravenous vasopressor, for example ephedrine (5 to 10 mg) 
or phenylephrine (50 to 100 µg).
Pruritus is more common after intrathecal than epidural 
or systemtic opioid administration. The cause is unknown; 
it is not histamine-related. The incidence and severity are 
dose related.99,100 The addition of local anesthetic to intrathe-
cal opioid decreases the incidence and severity of pruritus 
compared to opioid alone.101 Symptoms are usually worst 
during the initial 30 minutes after drug administration and 
are usually self-limiting. The one-time administration of 
naloxone (40 to 80 µg) or nalbuphine (2.5 to 5 mg) is effec-
tive for the treatment of severe pruritus.
Fetal bradycardia, not associated with maternal 
hypotension, sometimes occurs within 15 to 45 minutes after 
initiation of both epidural and CSE analgesia. The initiation 
of analgesia is associated with an acute decrease in mater-
nal plasma epinephrine levels.102 Epinephrine is a tocolytic. 
Clark and colleagues103 hypothesized that the acute decrease 
in circulating epinephrine concentration may result in tem-
porary imbalance of uterine tocolytic/tocodynamic forces, 
resulting in uterine hypertonus, decreased uterine perfusion, 
and ultimately, fetal bradycardia.
Published observations suggest that uterine hypertonus 
and fetal bradycardia may follow both intrathecal and epi-
dural analgesia during labor,104 although some observations 
suggest that is may occur more commonly after intrathecal 
opioid injection. In a systematic review of randomized 
comparisons of intrathecal opioid analgesia versus any non-
intrathecal opioid regimen in laboring women, intrathecal 
opioid analgesia resulted in a significant increase in the risk 
of fetal bradycardia (odds ratio 1.8; 95% confidence interval, 
1.0 to 3.1).105 Fortunately, fetal bradycardia associated with 
Table 3 Drugs for maintenance of epidural analgesiaa
Drug Concentration
Local anesthetics
  Bupivacaine 0.05%–0.1%
  ropivacaine 0.08%–0.2%
Opioids
  Fentanyl 1.5–3 µg/mL
  Sufentanil 0.2–0.33 µg/mL
aContinuous infusions usually consist of a local anesthetic combined with an opioid, 
administered at a rate of 8 to 15 mL/h into the lumbar epidural space.International Journal of Women’s Health 2009:1 149
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labor analgesia does not appear to have a detrimental effect on 
the outcome of labor. There is no evidence that the cesarean 
delivery rate is higher in women with neuraxial analgesia 
associated fetal bradycardia.105–107 The bradycardia usually 
resolves with conservative therapy, including discontinuing 
exogenous oxytocin and the administration of an intravenous 
fluid bolus. Nitroglycerine has been used successfully to treat 
uterine hypertonus associated with the initiation of neuraxial 
analgesia.108
Epidural labor analgesia greater than 6 hours is associated 
with maternal fever.109,110 The mechanism is unknown; it 
may be a result of increased heat production (eg, shivering), 
decreased heat loss (inhibition of sweating secondary to 
neuroblockade, or less heat loss via respiratory tract because 
of lack of hyperventilation), or alterations in temperature 
regulation induced by epidural analgesia.
Nausea and vomiting are common during labor; 
however, the incidence does not seem to worsen during 
neuraxial analgesia if hypotension is avoided. Shivering 
is frequently observed during labor and may occur more 
commonly after epidural analgesia.111 In an observational 
study, 18% of women shivered before delivery and 15% 
of these episodes were associated with normothermia and 
vasodilation, suggesting a nonthermoregulatory cause 
of the shivering.112 There was no difference in the inci-
dence of shivering between women who chose epidural 
(bupivacaine/fentanyl) compared to systemic meperidine 
analgesia.
Observational studies suggest that there is a higher risk 
of intrapartum and postpartum urinary retention in women 
who receive epidural labor analgesia compared to nonepi-
dural or no analgesia.113,114 It is unclear whether this finding 
reflects a cause-and-effect relationship or patient selection 
bias; however, differences among groups appear to resolve 
by postpartum day one.113 Parturients should be regularly 
observed during labor for evidence of bladder distention, 
especially if the patient complains of suprapubic pain dur-
ing a contraction or breakthrough pain. Personal observation 
suggests that many women can void in the presence of low-
dose neuroblockade if escorted to the toilet or offered a bed 
pan. Inability to void and bladder distention should prompt 
catheterization to empty the bladder.
Complications of neuraxial analgesia include uninten-
tional dural puncture with an epidural needle (incidence 
approximately 1.5%).115 Fortunately, serious complica-
tions of neuraxial analgesia (respiratory depression/arrest, 
total spinal anesthesia, systemic local anesthetic toxicity 
secondary to inadvertent intravascular injection of local 
anesthetic, and neuraxial infection) are rare. Although 30% 
to 50% of women complain of back pain after delivery,116,117 
prospective reports118 and randomized controlled trials116,119 
have failed to show a significant relationship between the use 
of epidural analgesia and long-term backache.
Breakthrough pain may result from inadequate extent 
of blockade, either caudad (sacral dermatomes) or cephalad 
(low thoracic dermatomes), inadequate density of blockade, 
or unilateral/patchy blockade. Women with rapid progress 
of labor often have inadequate sacral analgesia. Women in 
late labor require a denser block, as do women with large 
or malrotated fetuses, or dysfunctional labor.120 Analgesia 
is reestablished by the incremental injection of more con-
centrated local anesthetic solution or additional opioid, or a 
combination of the two, and then increasing the maintenance 
dose as necessary.
Fetal and neonatal effects  
of neuraxial analgesia
Neuraxial analgesia may affect the fetus directly or indirectly, 
or both. The neonatal depressant effects of drugs adminis-
tered to the mother in the intrapartum period are usually 
assessed with neurobehavioral testing. Unfortunately, these 
tests are quite subjective and lack specificity. Additionally, 
scientifically rigorous studies are lacking and most of the 
local anesthetic studies were performed in the era when high-
dose epidural analgesia was common. There is no evidence 
for a direct effect of low-dose local anesthetic/opioid neur-
axial analgesia. Compared to epidural bupivacaine analgesia, 
systemic meperidine analgesia is associated with a greater 
loss of FHR variability and fewer FHR accelerations,47 and 
a higher incidence of neonatal respiratory depression.121
The indirect fetal effects of epidural and intrathecal opi-
oids may be more significant than the direct effects. Maternal 
hypotension may cause a decrease in uteroplacental perfusion 
and fetal oxygenation. Obviously, if the mother has severe 
respiratory depression and hypoxemia, fetal hypoxemia and 
hypoxia will follow.122 Fetal bradycardia after initiation of 
neuraxial analgesia was discussed previously.
Other regional analgesic techniques
Although neuraxial analgesia is the most effective and 
flexible analgesic technique for labor and delivery, some 
parturients may not be candidates for neuraxial analgesia, 
or may not want it. Other nerve blocks provide acceptable, 
albeit less flexible, analgesia.
Bilateral deposition of local anesthetic around the para-
cervical (Frankenhäuser’s) ganglia blocks transmission of International Journal of Women’s Health 2009:1 150
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visceral afferent impulses from the uterus and cervix. The 
block provides analgesia for the first stage of labor, before fetal 
descent, without somatic sensory or motor block. However, 
analgesia is not continuous and the somatic pain caused by dis-
tension of the pelvic floor, vagina or perineum is unrelieved.
Serious maternal complications are uncommon. Fetal bra-
dycardia is the most common fetal complication; the etiology 
is unknown. Inadvertent direct fetal scalp injection has been 
reported123 and may be more likely to occur when the block 
is performed with advanced cervical dilation (8 cm).
Similar to a paracervical block, paravertebral lumbar 
sympathetic blockade interferes with transmission of visceral 
afferent nerve impulses from the uterus and cervix and pro-
vides analgesia for the first stage, but not the second stage 
of labor. The technique is not continuous, it is technically 
more difficult to learn and perform, and requires bilateral 
injections. However, it is associated with less fetal bradycar-
dia than a paracervical block, provides first stage analgesia 
without any motor block, and may be useful for patients 
with previous back surgery. Labor progress is accelerated 
compared to epidural analgesia.124
Bilateral blockade of the pudendal nerve provides vagi-
nal, vulvar and perineal anesthesia. The resulting anesthesia is 
adequate for spontaneous vaginal and low- or outlet-forceps 
delivery, but not mid-forceps delivery or exploration of the 
upper vagina, cervix or uterine cavities. Bilateral success 
rate may be a low as 50%.125 The pudendal nerve can be 
blocked via the transperineal or transvaginal route. Most 
obstetricians in the United States employ the transvaginal 
route immediately before delivery. Earlier pudendal nerve 
blocks (just before or after complete cervical dilation) provide 
better analgesia, do not increase the incidence of instrumental 
delivery, and allow for a repeat block should the initial block 
fail. Maternal and fetal complications of pudendal nerve 
block are unusual. Fetal complications include fetal trauma 
and/or direct fetal injection of local anesthetic.126
Perineal infiltration of local anesthetic is often done 
immediately before delivery to provide anesthesia for an 
episiotomy or repair. It provides no motor relaxation. The 
injection may be complicated by direct injection of local 
anesthetic into the fetal scalp resulting in neonatal local 
anesthetic toxicity.
Effects of analgesia on the progress 
and outcome of labor
Controversy has surrounded the issue of the effect of 
neuraxial labor analgesia on the progress of labor and 
mode of delivery. Although early investigators noted that 
neuraxial analgesia appeared to be an effective treatment 
for dysfunctional labor,17,127,128 observational studies 
uniformly found an association between neuraxial analgesia, 
prolonged labor, and operative delivery. However, random-
ized controlled trials comparing neuraxial labor analgesia 
to systemic opioid analgesia have found no difference in 
the rate of cesarean delivery between groups.129,130 Women 
with more pain during labor (and thus more likely to request 
analgesia) have a higher risk of cesarean delivery;8,9,131 
this association may explain the observed association 
between neuraxial analgesia and operative delivery. Fetal 
macrosomia, malposition, and dysfunctional labor are 
associated with more painful labor and a higher rate of 
cesarean delivery.
Another concern has been whether early labor (latent 
phase) initiation of neuraxial analgesia adversely affects the 
outcome of labor. Again, observational studies suggest that 
initiation of neuraxial analgesia in early labor is associated 
with an increased rate of cesarean delivery. Randomized 
controlled trials, however, have uniformly demonstrated that 
early labor neuraxial compared to systemic opioid analgesia 
does not adversely affect the progress and outcome of 
labor,62,132–134 and may actually result in faster labor.62,134
Randomized controlled trials comparing neuraxial to sys-
temic opioid analgesia have assessed the risk of instrumental 
vaginal delivery and duration of labor as secondary out-
comes. Systematic review of these trials have concluded 
that the duration of the first and second stages of labor may 
be prolonged by approximately 30 and 15 minutes, respec-
tively, and the rate of instrumental forceps delivery may be 
increased.129,130 However, the treatment (neuraxial) group 
in many of the trials received epidural analgesia with bupi-
vacaine 2.5 mg/mL, a much higher dose than is the current 
norm. Indeed, several groups of investigators have demon-
strated that neuraxial analgesia with this technique results 
in a higher instrumental vaginal delivery rate compared to 
low-dose bupivacaine-opioid techniques.67,135 Thus, the goal 
of the anesthesia provider should be to provide analgesia 
with minimal motor blockade in order to decrease the risk 
of instrumental vaginal delivery.
No randomized trials have compared neuraxial or sys-
temic opioid analgesia to no analgesia. For ethical reasons, 
these trials are unlikely to ever be completed. Therefore, the 
effect of any type of analgesia, be it neuraxial or systemic, 
on the outcome of labor is not known.
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